Cumberland Pharmaceuticals Inc. Amortization of Intangible Assets
Cumberland Pharmaceuticals Inc. (CPIX) reported Amortization of Intangible Assets of $7.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $7.15K, a 23.96% increase year-over-year.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $1.25M, a 24.23% increase year-over-year.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $1.01M, a 30.57% decline year-over-year.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $1.01M, a 6.37% decline year-over-year.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for fiscal 2025 was $4.03M, a 15.03% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for fiscal 2024 was $4.75M, a 41.40% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for fiscal 2023 was $8.10M, a 59.90% increase from fiscal 2022.
- Cumberland Pharmaceuticals Inc. amortization of intangible assets for fiscal 2022 was $5.07M, a 15.92% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.15K 10-Q · filed 2026-08-07 | $14.15K 10-Q · filed 2026-08-07 | $2.27M derived: sum of 3 quarters · filed 2026-08-07 | $3.28M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-08 | $2.26M derived: sum of 2 quarters · filed 2026-05-08 | $3.27M derived: sum of 3 quarters · filed 2026-05-08 | $3.28M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.02M derived: sum of 2 quarters · filed 2026-03-09 | $2.03M derived: sum of 3 quarters · filed 2026-08-07 | $4.03M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $1.01M 10-Q · filed 2025-11-07 | $1.02M derived: sum of 2 quarters · filed 2026-08-07 | $3.02M 10-Q · filed 2025-11-07 | $3.48M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $5.77K 10-Q · filed 2026-08-07 | $1.01M 10-Q · filed 2025-08-08 | $11.84K 10-Q · filed 2026-08-07 | $2.01M 10-Q · filed 2025-08-08 | $2.47M derived: sum of 3 quarters · filed 2026-08-07 | $3.55M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $1.01M 10-Q · filed 2026-05-08 | $2.46M derived: sum of 2 quarters · filed 2026-05-08 | $3.54M derived: sum of 3 quarters · filed 2026-05-08 | $4.64M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.54M derived: sum of 2 quarters · filed 2026-03-09 | $3.64M derived: sum of 3 quarters · filed 2026-03-09 | $4.75M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $1.08M 10-Q · filed 2025-11-07 | $2.18M derived: sum of 2 quarters · filed 2025-11-07 | $3.29M 10-Q · filed 2025-11-07 | $7.83M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $1.10M 10-Q · filed 2025-08-08 | $2.21M 10-Q · filed 2025-08-08 | $6.75M derived: sum of 3 quarters · filed 2025-08-08 | $7.92M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $1.11M 10-Q · filed 2025-05-09 | $5.65M derived: sum of 2 quarters · filed 2025-05-09 | $6.82M derived: sum of 3 quarters · filed 2025-05-09 | $7.98M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $5.71M derived: sum of 2 quarters · filed 2025-03-07 | $6.87M derived: sum of 3 quarters · filed 2025-03-07 | $8.10M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $1.18M 10-Q · filed 2024-11-08 | $2.33M derived: sum of 2 quarters · filed 2024-11-08 | $3.56M 10-Q · filed 2024-11-08 | $4.02M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $1.16M 10-Q · filed 2024-08-09 | $2.39M 10-Q · filed 2024-08-09 | $2.85M derived: sum of 3 quarters · filed 2024-08-09 | $4.33M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.23M 10-Q · filed 2024-05-10 | $1.69M derived: sum of 2 quarters · filed 2024-05-10 | $3.17M derived: sum of 3 quarters · filed 2024-05-10 | $4.70M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $458.22K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.94M derived: sum of 2 quarters · filed 2024-03-13 | $3.47M derived: sum of 3 quarters · filed 2024-03-13 | $5.07M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $1.49M 10-Q · filed 2023-11-13 | $3.02M derived: sum of 2 quarters · filed 2023-11-13 | $4.61M 10-Q · filed 2023-11-13 | $5.63M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.53M 10-Q · filed 2023-08-11 | $3.12M 10-Q · filed 2023-08-11 | $4.14M derived: sum of 3 quarters · filed 2023-08-11 | $5.15M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $1.59M 10-Q · filed 2023-05-12 | $2.61M derived: sum of 2 quarters · filed 2023-05-12 | $3.62M derived: sum of 3 quarters · filed 2023-05-12 | $4.80M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $2.03M derived: sum of 2 quarters · filed 2023-03-13 | $3.20M derived: sum of 3 quarters · filed 2023-03-13 | $4.37M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $1.01M 10-Q · filed 2022-11-14 | $2.19M derived: sum of 2 quarters · filed 2022-11-14 | $3.35M 10-Q · filed 2022-11-14 | $4.50M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.17M 10-Q · filed 2022-08-12 | $2.34M 10-Q · filed 2022-08-12 | $3.49M derived: sum of 3 quarters · filed 2022-08-12 | $4.61M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $1.17M 10-Q · filed 2022-05-13 | $2.32M derived: sum of 2 quarters · filed 2022-05-13 | $3.44M derived: sum of 3 quarters · filed 2022-05-13 | $4.53M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.27M derived: sum of 2 quarters · filed 2022-03-11 | $3.36M derived: sum of 3 quarters · filed 2022-03-11 | $4.43M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.12M 10-Q · filed 2021-11-12 | $2.21M derived: sum of 2 quarters · filed 2021-11-12 | $3.28M 10-Q · filed 2021-11-12 | $4.33M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $1.09M 10-Q · filed 2021-08-13 | $2.17M 10-Q · filed 2021-08-13 | $3.22M derived: sum of 3 quarters · filed 2022-03-11 | $4.25M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $1.08M 10-Q · filed 2021-05-14 | $2.13M derived: sum of 2 quarters · filed 2022-03-11 | $3.16M derived: sum of 3 quarters · filed 2022-03-11 | $4.19M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.08M derived: sum of 2 quarters · filed 2022-03-11 | $3.11M derived: sum of 3 quarters · filed 2022-03-11 | $4.13M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $1.03M 10-Q · filed 2020-11-13 | $2.06M derived: sum of 2 quarters · filed 2020-11-13 | $3.09M 10-Q · filed 2020-11-13 | $3.91M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-06-30 | $1.03M 10-Q · filed 2020-08-14 | $2.05M 10-Q · filed 2020-08-14 | $2.87M derived: sum of 3 quarters · filed 2021-03-12 | $3.54M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $1.02M 10-Q · filed 2020-05-22 | $1.84M derived: sum of 2 quarters · filed 2021-03-12 | $2.51M derived: sum of 3 quarters · filed 2021-03-12 | $3.15M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | $823.01K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.48M derived: sum of 2 quarters · filed 2021-03-12 | $2.13M derived: sum of 3 quarters · filed 2021-03-12 | $2.77M 10-K · filed 2021-03-12 | ||||
| 2018-09-30 | $661.80K 10-Q · filed 2019-11-13 | $1.31M derived: sum of 2 quarters · filed 2019-11-13 | $1.95M 10-Q · filed 2019-11-13 | $2.57M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-06-30 | $648.52K 10-Q · filed 2019-08-14 | $1.28M 10-Q · filed 2019-08-14 | $1.91M derived: sum of 3 quarters · filed 2020-12-10 | $2.52M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2018-03-31 | $636.13K 10-Q · filed 2019-05-15 | $1.26M derived: sum of 2 quarters · filed 2020-12-10 | $1.87M derived: sum of 3 quarters · filed 2020-12-10 | $2.46M derived: sum of 4 quarters · filed 2020-12-10 | ||||
| 2017-12-31 | $624.63K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $1.23M derived: sum of 2 quarters · filed 2020-12-10 | $1.82M derived: sum of 3 quarters · filed 2020-12-10 | $2.44M 8-K · filed 2020-12-10 | ||||
| 2017-09-30 | $609.57K 10-Q · filed 2018-11-14 | $1.20M derived: sum of 2 quarters · filed 2018-11-14 | $1.81M 10-Q · filed 2018-11-14 | $2.37M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $590.57K 10-Q · filed 2018-08-14 | $1.20M 10-Q · filed 2018-08-14 | $1.76M derived: sum of 3 quarters · filed 2019-03-12 | $2.33M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $611.44K 10-Q · filed 2018-05-09 | $1.17M derived: sum of 2 quarters · filed 2019-03-12 | $1.74M derived: sum of 3 quarters · filed 2019-03-12 | $2.27M derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $561.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.12M derived: sum of 2 quarters · filed 2019-03-12 | $1.66M derived: sum of 3 quarters · filed 2019-03-12 | $2.19M 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $562.72K 10-Q · filed 2017-11-08 | $1.10M derived: sum of 2 quarters · filed 2017-11-08 | $1.63M 10-Q · filed 2017-11-08 | $2.15M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | $539.43K 10-Q · filed 2017-08-09 | $1.07M 10-Q · filed 2017-08-09 | $1.59M derived: sum of 3 quarters · filed 2018-03-09 | $2.06M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | $530.77K 10-Q · filed 2017-05-15 | $1.05M derived: sum of 2 quarters · filed 2018-03-09 | $1.52M derived: sum of 3 quarters · filed 2018-03-09 | $2.03M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | $517.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $990.82K derived: sum of 2 quarters · filed 2018-03-09 | $1.50M derived: sum of 3 quarters · filed 2018-03-09 | $1.99M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | $473.44K 10-Q · filed 2016-11-03 | $985.13K derived: sum of 2 quarters · filed 2016-11-03 | $1.47M 10-Q · filed 2016-11-03 | $1.98M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $511.69K 10-Q · filed 2016-08-05 | $998.44K 10-Q · filed 2016-08-05 | $1.51M derived: sum of 3 quarters · filed 2017-03-13 | $2.00M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $486.75K 10-Q · filed 2016-05-13 | $999.73K derived: sum of 2 quarters · filed 2017-03-13 | $1.49M derived: sum of 3 quarters · filed 2017-03-13 | $1.79M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2014-12-31 | $512.98K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $998.48K derived: sum of 2 quarters · filed 2017-03-13 | $1.30M derived: sum of 3 quarters · filed 2017-03-13 | $1.60M 10-K · filed 2017-03-13 | ||||
| 2014-09-30 | $485.49K 10-Q · filed 2015-11-06 | $789.75K derived: sum of 2 quarters · filed 2015-11-06 | $1.08M 10-Q · filed 2015-11-06 | $1.37M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $304.26K 10-Q · filed 2015-08-07 | $598.21K 10-Q · filed 2015-08-07 | $883.69K derived: sum of 3 quarters · filed 2016-03-14 | $1.09M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $293.95K 10-Q · filed 2015-05-15 | $579.43K derived: sum of 2 quarters · filed 2016-03-14 | $782.42K derived: sum of 3 quarters · filed 2016-03-14 | $1.07M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $285.48K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $488.46K derived: sum of 2 quarters · filed 2016-03-14 | $771.11K derived: sum of 3 quarters · filed 2016-03-14 | $896.16K 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $202.98K 10-Q · filed 2014-11-07 | $485.63K derived: sum of 2 quarters · filed 2014-11-07 | $610.68K 10-Q · filed 2014-11-07 | $745.08K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $282.64K 10-Q · filed 2014-08-08 | $407.69K 10-Q · filed 2014-08-08 | $542.10K derived: sum of 3 quarters · filed 2015-03-09 | $670.80K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $125.05K 10-Q · filed 2014-05-12 | $259.45K derived: sum of 2 quarters · filed 2015-03-09 | $388.16K derived: sum of 3 quarters · filed 2015-03-09 | $519.34K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $134.40K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $263.11K derived: sum of 2 quarters · filed 2015-03-09 | $394.29K derived: sum of 3 quarters · filed 2015-03-09 | $506.33K 10-K · filed 2015-03-09 | $466.13K 10-K · filed 2013-03-12 | |||
| 2012-09-30 | $128.70K 10-Q · filed 2013-11-06 | $117.56K 10-Q · filed 2012-11-02 | $259.88K derived: sum of 2 quarters · filed 2013-11-06 | $371.93K 10-Q · filed 2013-11-06 | $344.21K 10-Q · filed 2012-11-02 | $512.05K derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-06-30 | $131.18K 10-Q · filed 2013-08-09 | $114.60K 10-Q · filed 2012-08-09 | $243.23K 10-Q · filed 2013-08-09 | $226.65K 10-Q · filed 2012-08-09 | $383.35K derived: sum of 3 quarters · filed 2014-03-11 | $555.08K derived: sum of 4 quarters · filed 2014-03-11 | ||
| 2012-03-31 | $112.05K 10-Q · filed 2013-05-08 | $252.17K derived: sum of 2 quarters · filed 2014-03-11 | $423.90K derived: sum of 3 quarters · filed 2014-03-11 | $595.62K derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | $140.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $311.85K derived: sum of 2 quarters · filed 2014-03-11 | $483.57K derived: sum of 3 quarters · filed 2014-03-11 | $655.30K 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | $171.73K 10-Q · filed 2012-11-02 | $343.45K derived: sum of 2 quarters · filed 2012-11-02 | $515.18K 10-Q · filed 2012-11-02 | $686.91K derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-06-30 | $171.73K 10-Q · filed 2012-08-09 | $343.45K 10-Q · filed 2012-08-09 | $515.18K derived: sum of 3 quarters · filed 2013-03-12 | $686.91K derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2011-03-31 | $171.73K 10-Q · filed 2012-05-04 | $343.45K derived: sum of 2 quarters · filed 2013-03-12 | $515.19K derived: sum of 3 quarters · filed 2013-03-12 | $686.91K derived: sum of 4 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | $171.73K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $343.46K derived: sum of 2 quarters · filed 2013-03-12 | $515.18K derived: sum of 3 quarters · filed 2013-03-12 | $686.91K 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | $171.73K 10-Q · filed 2011-11-07 | $343.46K derived: sum of 2 quarters · filed 2011-11-07 | $515.18K 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | $171.73K 10-Q · filed 2011-08-08 | $343.45K 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $686.90K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |